{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T22:00:18Z","timestamp":1648936818307},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11739-016-1463-1","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T09:22:35Z","timestamp":1464081755000},"page":"1037-1040","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?"],"prefix":"10.1007","volume":"11","author":[{"given":"Aaron","family":"Liew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Douketis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,23]]},"reference":[{"key":"1463_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-016-1416-8","author":"F Violi","year":"2016","unstructured":"Violi F, Corazza RG, Caldwell SH, Perticone F, Gatta A, Angelico M, Farcomeni A, Masotti M, Napoleone L, Vestri A, Raparelli V, Basili S, Collaborators P-L (2016) Portal vein thrombosis relevance on liver cirrhosis: italian Venous Thrombotic Events Registry. Intern Emerg Med. doi: 10.1007\/s11739-016-1416-8","journal-title":"Intern Emerg Med"},{"issue":"3","key":"1463_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11739-008-0128-0","volume":"3","author":"FL Fimognari","year":"2008","unstructured":"Fimognari FL, Violi F (2008) Portal vein thrombosis in liver cirrhosis. Intern Emerg Med 3(3):213\u2013218. doi: 10.1007\/s11739-008-0128-0","journal-title":"Intern Emerg Med"},{"issue":"5","key":"1463_CR3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/hep.22772","volume":"49","author":"LD DeLeve","year":"2009","unstructured":"DeLeve LD, Valla DC, Garcia-Tsao G, American Association for the Study Liver Diseases (2009) Vascular disorders of the liver. Hepatology 49(5):1729\u20131764. doi: 10.1002\/hep.22772","journal-title":"Hepatology"},{"issue":"7","key":"1463_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2010.11.006","volume":"43","author":"M Senzolo","year":"2011","unstructured":"Senzolo M, Riggio O, Primignani M, Italian Association for the Study of the Liver ad hoc (2011) Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. Dig Liver Dis 43(7):503\u2013514. doi: 10.1016\/j.dld.2010.11.006","journal-title":"Dig Liver Dis"},{"issue":"27","key":"1463_CR5","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.4254\/wjh.v7.i27.2774","volume":"7","author":"JG Stine","year":"2015","unstructured":"Stine JG, Shah PM, Cornella SL, Rudnick SR, Ghabril MS, Stukenborg GJ, Northup PG (2015) Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: a meta-analysis. World J Hepatol 7(27):2774\u20132780. doi: 10.4254\/wjh.v7.i27.2774","journal-title":"World J Hepatol"},{"issue":"1","key":"1463_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejim.2014.12.002","volume":"26","author":"X Qi","year":"2015","unstructured":"Qi X, De Stefano V, Li H, Dai J, Guo X, Fan D (2015) Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Eur J Intern Med 26(1):23\u201329. doi: 10.1016\/j.ejim.2014.12.002","journal-title":"Eur J Intern Med"},{"issue":"7","key":"1463_CR7","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","volume":"10","author":"MG Delgado","year":"2012","unstructured":"Delgado MG, Seijo S, Yepes I, Achecar L, Catalina MV, Garcia-Criado A, Abraldes JG, de la Pena J, Banares R, Albillos A, Bosch J, Garcia-Pagan JC (2012) Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 10(7):776\u2013783. doi: 10.1016\/j.cgh.2012.01.012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"1463_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3350\/cmh.2014.20.4.384","volume":"20","author":"JW Chung","year":"2014","unstructured":"Chung JW, Kim GH, Lee JH, Ok KS, Jang ES, Jeong SH, Kim JW (2014) Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis. Clin Mol Hepatol 20(4):384\u2013391. doi: 10.3350\/cmh.2014.20.4.384","journal-title":"Clin Mol Hepatol"},{"issue":"2 Suppl","key":"1463_CR9","doi-asserted-by":"publisher","first-page":"e419S","DOI":"10.1378\/chest.11-2301","volume":"141","author":"C Kearon","year":"2012","unstructured":"Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR, American College of Chest Physicians (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e419S\u2013e494S. doi: 10.1378\/chest.11-2301","journal-title":"Chest"},{"issue":"3","key":"1463_CR10","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R Franchis de","year":"2015","unstructured":"de Franchis R, Baveno VIF (2015) Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 63(3):743\u2013752. doi: 10.1016\/j.jhep.2015.05.022","journal-title":"J Hepatol"},{"issue":"6","key":"1463_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11739-010-0413-6","volume":"5","author":"V Stefano De","year":"2010","unstructured":"De Stefano V, Martinelli I (2010) Splanchnic vein thrombosis: clinical presentation, risk factors and treatment. Intern Emerg Med 5(6):487\u2013494. doi: 10.1007\/s11739-010-0413-6","journal-title":"Intern Emerg Med"},{"issue":"6","key":"1463_CR12","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/01.ta.0000197354.69796.bd","volume":"59","author":"CE Haas","year":"2005","unstructured":"Haas CE, Nelsen JL, Raghavendran K, Mihalko W, Beres J, Ma Q, Forrest A (2005) Pharmacokinetics and pharmacodynamics of enoxaparin in multiple trauma patients. J Trauma 59(6):1336\u20131343 (discussion 1343\u20131334)","journal-title":"J Trauma"},{"issue":"1","key":"1463_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cld.2008.09.009","volume":"13","author":"R Arjal","year":"2009","unstructured":"Arjal R, Trotter JF (2009) International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure. Clin Liver Dis 13(1):67\u201371. doi: 10.1016\/j.cld.2008.09.009","journal-title":"Clin Liver Dis"},{"issue":"2","key":"1463_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11739-016-1398-6","volume":"11","author":"G Finazzi","year":"2016","unstructured":"Finazzi G, Ageno W (2016) Direct oral anticoagulants in rare venous thrombosis. Intern Emerg Med 11(2):167\u2013170. doi: 10.1007\/s11739-016-1398-6","journal-title":"Intern Emerg Med"},{"issue":"5","key":"1463_CR15","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/bjh.12593","volume":"163","author":"W Potze","year":"2013","unstructured":"Potze W, Arshad F, Adelmeijer J, Blokzijl H, van den Berg AP, Porte RJ, Lisman T (2013) Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis. Br J Haematol 163(5):666\u2013673. doi: 10.1111\/bjh.12593","journal-title":"Br J Haematol"},{"key":"1463_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/VHRM.S89130","volume":"12","author":"TY Hu","year":"2016","unstructured":"Hu TY, Vaidya VR, Asirvatham SJ (2016) Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab. Vasc Health Risk Manag 12:35\u201344. doi: 10.2147\/VHRM.S89130","journal-title":"Vasc Health Risk Manag"},{"issue":"2","key":"1463_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/MBC.0000000000000442","volume":"27","author":"AN Aslan","year":"2016","unstructured":"Aslan AN, Sari C, Bastug S, Sari SO, Akcay M, Durmaz T, Bozkurt E (2016) Severe jaundice due to intrahepatic cholestasis after initiating anticoagulation with rivaroxaban. Blood Coagul Fibrinolysis 27(2):226\u2013227. doi: 10.1097\/MBC.0000000000000442","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"1463_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/MBC.0000000000000363","volume":"26","author":"EJ Anastasia","year":"2015","unstructured":"Anastasia EJ, Rosenstein RS, Bergsman JA, Parra D (2015) Use of apixaban after development of suspected rivaroxaban-induced hepatic steatosis; a case report. Blood Coagul Fibrinolysis 26(6):699\u2013702. doi: 10.1097\/MBC.0000000000000363","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"10","key":"1463_CR19","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jamainternmed.2014.3912","volume":"174","author":"E Liakoni","year":"2014","unstructured":"Liakoni E, Ratz Bravo AE, Terracciano L, Heim M, Krahenbuhl S (2014) Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban. JAMA Intern Med 174(10):1683\u20131686. doi: 10.1001\/jamainternmed.2014.3912","journal-title":"JAMA Intern Med"},{"issue":"2","key":"1463_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jhep.2014.03.026","volume":"61","author":"S Russmann","year":"2014","unstructured":"Russmann S, Niedrig DF, Budmiger M, Schmidt C, Stieger B, Hurlimann S, Kullak-Ublick GA (2014) Rivaroxaban postmarketing risk of liver injury. J Hepatol 61(2):293\u2013300. doi: 10.1016\/j.jhep.2014.03.026","journal-title":"J Hepatol"},{"issue":"3","key":"1463_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2165\/11586600-000000000-00000","volume":"34","author":"PB Watkins","year":"2011","unstructured":"Watkins PB, Desai M, Berkowitz SD, Peters G, Horsmans Y, Larrey D, Maddrey W (2011) Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery. Drug Saf 34(3):243\u2013252. doi: 10.2165\/11586600-000000000-00000","journal-title":"Drug Saf"},{"issue":"1","key":"1463_CR22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.18433\/J33P49","volume":"16","author":"M Bondarenko","year":"2013","unstructured":"Bondarenko M, Curti C, Montana M, Rathelot P, Vanelle P (2013) Efficacy and toxicity of factor Xa inhibitors. J Pharm Pharm Sci 16(1):74\u201388","journal-title":"J Pharm Pharm Sci"},{"issue":"9","key":"1463_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4103\/1947-2714.166221","volume":"7","author":"M Baig","year":"2015","unstructured":"Baig M, Wool KJ, Halanych JH, Sarmad RA (2015) Acute liver failure after initiation of rivaroxaban: a case report and review of the literature. N Am J Med Sci 7(9):407\u2013410. doi: 10.4103\/1947-2714.166221","journal-title":"N Am J Med Sci"},{"issue":"11\u201312","key":"1463_CR24","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/apt.13412","volume":"42","author":"D Caldeira","year":"2015","unstructured":"Caldeira D, Barra M, Ferreira A, Rocha A, Augusto A, Pinto FJ, Costa J, Ferreira JJ (2015) Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants. Aliment Pharmacol Ther 42(11\u201312):1239\u20131249. doi: 10.1111\/apt.13412","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"1463_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.dld.2015.01.159","volume":"47","author":"L Loffredo","year":"2015","unstructured":"Loffredo L, Perri L, Violi F (2015) Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: a meta-analysis of interventional trials. Dig Liver Dis 47(5):429\u2013431. doi: 10.1016\/j.dld.2015.01.159","journal-title":"Dig Liver Dis"},{"issue":"3","key":"1463_CR26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1053\/j.gastro.2015.05.002","volume":"149","author":"EW Chan","year":"2015","unstructured":"Chan EW, Lau WC, Leung WK, Mok MT, He Y, Tong TS, Wong IC (2015) Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study. Gastroenterology 149(3):586\u2013595 e583. doi: 10.1053\/j.gastro.2015.05.002","journal-title":"Gastroenterology"},{"issue":"7","key":"1463_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/heartjnl-2013-305288","volume":"100","author":"D Caldeira","year":"2014","unstructured":"Caldeira D, Barra M, Santos AT, de Abreu D, Pinto FJ, Ferreira JJ, Costa J (2014) Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis. Heart 100(7):550\u2013556. doi: 10.1136\/heartjnl-2013-305288","journal-title":"Heart"},{"issue":"10","key":"1463_CR28","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1055\/s-0034-1385171","volume":"52","author":"K Lenz","year":"2014","unstructured":"Lenz K, Dieplinger B, Buder R, Piringer P, Rauch M, Voglmayr M (2014) Successful treatment of partial portal vein thrombosis (PVT) with low dose rivaroxaban. Z Gastroenterol 52(10):1175\u20131177. doi: 10.1055\/s-0034-1385171","journal-title":"Z Gastroenterol"},{"issue":"4","key":"1463_CR29","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1160\/TH13-05-0407","volume":"110","author":"S Pannach","year":"2013","unstructured":"Pannach S, Babatz J, Beyer-Westendorf J (2013) Successful treatment of acute portal vein thrombosis with rivaroxaban. Thromb Haemost 110(4):626\u2013627. doi: 10.1160\/TH13-05-0407","journal-title":"Thromb Haemost"},{"issue":"2","key":"1463_CR30","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/hep.27225","volume":"61","author":"NM Intagliata","year":"2015","unstructured":"Intagliata NM, Maitland H, Northup PG, Caldwell SH (2015) Treating thrombosis in cirrhosis patients with new oral agents: ready or not? Hepatology 61(2):738\u2013739. doi: 10.1002\/hep.27225","journal-title":"Hepatology"},{"issue":"1","key":"1463_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/hep.26998","volume":"60","author":"M Martinez","year":"2014","unstructured":"Martinez M, Tandra A, Vuppalanchi R (2014) Treatment of acute portal vein thrombosis by nontraditional anticoagulation. Hepatology 60(1):425\u2013426. doi: 10.1002\/hep.26998","journal-title":"Hepatology"},{"key":"1463_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-4012-2","author":"NM Intagliata","year":"2016","unstructured":"Intagliata NM, Henry ZH, Maitland H, Shah NL, Argo CK, Northup PG, Caldwell SH (2016) Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation. Dig Dis Sci. doi: 10.1007\/s10620-015-4012-2","journal-title":"Dig Dis Sci"},{"issue":"4","key":"1463_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40262-013-0034-0","volume":"52","author":"J Graff","year":"2013","unstructured":"Graff J, Harder S (2013) Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment. Clin Pharmacokinet 52(4):243\u2013254. doi: 10.1007\/s40262-013-0034-0","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"1463_CR34","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/hep.27350","volume":"61","author":"W Potze","year":"2015","unstructured":"Potze W, Adelmeijer J, Lisman T (2015) Decreased in vitro anticoagulant potency of rivaroxaban and apixaban in plasma from patients with cirrhosis. Hepatology 61(4):1435\u20131436. doi: 10.1002\/hep.27350","journal-title":"Hepatology"},{"issue":"1","key":"1463_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/bcp.12054","volume":"76","author":"D Kubitza","year":"2013","unstructured":"Kubitza D, Roth A, Becka M, Alatrach A, Halabi A, Hinrichsen H, Mueck W (2013) Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor. Br J Clin Pharmacol 76(1):89\u201398. doi: 10.1111\/bcp.12054","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1463_CR36","doi-asserted-by":"publisher","first-page":"e88390","DOI":"10.1371\/journal.pone.0088390","volume":"9","author":"W Potze","year":"2014","unstructured":"Potze W, Arshad F, Adelmeijer J, Blokzijl H, van den Berg AP, Meijers JC, Porte RJ, Lisman T (2014) Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis. PLoS One 9(2):e88390. doi: 10.1371\/journal.pone.0088390","journal-title":"PLoS One"},{"issue":"9","key":"1463_CR37","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","volume":"175","author":"W Ageno","year":"2015","unstructured":"Ageno W, Riva N, Schulman S, Beyer-Westendorf J, Bang SM, Senzolo M, Grandone E, Pasca S, Di Minno MN, Duce R, Malato A, Santoro R, Poli D, Verhamme P, Martinelli I, Kamphuisen P, Oh D, D\u2019Amico E, Becattini C, De Stefano V, Vidili G, Vaccarino A, Nardo B, Di Nisio M, Dentali F (2015) Long-term clinical outcomes of splanchnic vein thrombosis: results of an International Registry. JAMA Intern Med 175(9):1474\u20131480. doi: 10.1001\/jamainternmed.2015.3184","journal-title":"JAMA Intern Med"},{"issue":"6","key":"1463_CR38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/jth.12930","volume":"13","author":"N Riva","year":"2015","unstructured":"Riva N, Ageno W, Poli D, Testa S, Rupoli S, Santoro R, Lerede T, Piana A, Carpenedo M, Nicolini A, Ferrini PM, Tosetto A, Italian Federation of Anticoagulation Clinics (FCSA) (2015) Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study. J Thromb Haemost 13(6):1019\u20131027. doi: 10.1111\/jth.12930","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1463_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/s-0033-1363473","volume":"40","author":"W Ageno","year":"2014","unstructured":"Ageno W, Riva N, Schulman S, Bang SM, Sartori MT, Grandone E, Beyer-Westendorf J, Barillari G, Di Minno MN, Dentali F, IRSVT Study Group (2014) Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry. Semin Thromb Hemost 40(1):99\u2013105. doi: 10.1055\/s-0033-1363473","journal-title":"Semin Thromb Hemost"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-016-1463-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-016-1463-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-016-1463-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-016-1463-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T17:28:57Z","timestamp":1559410137000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-016-1463-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1463"],"URL":"https:\/\/doi.org\/10.1007\/s11739-016-1463-1","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]}}}